Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Net Income | -10.89% | 4.70% | |||
| Total Depreciation and Amortization | 1.65% | 44.76% | |||
| Total Amortization of Deferred Charges | -- | -92.03% | |||
| Total Other Non-Cash Items | 24.45% | -77.32% | |||
| Change in Net Operating Assets | 587.43% | 5,353.57% | |||
| Cash from Operations | 7.44% | 11.07% | |||
| Capital Expenditure | 74.65% | 94.75% | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | -69.47% | -169.33% | |||
| Cash from Investing | -69.41% | -153.17% | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 181.82% | 117.78% | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -100.00% | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | 53.12% | 92.46% | |||
| Cash from Financing | 55.20% | -99.95% | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | -437.24% | -188.01% | |||